6-(4-(4-chlorobenzyloxy)phenyl)-1,3,5-triazine-2,4-diamine

ID: ALA4169358

Chembl Id: CHEMBL4169358

PubChem CID: 21705470

Max Phase: Preclinical

Molecular Formula: C16H14ClN5O

Molecular Weight: 327.78

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Nc1nc(N)nc(-c2ccc(OCc3ccc(Cl)cc3)cc2)n1

Standard InChI:  InChI=1S/C16H14ClN5O/c17-12-5-1-10(2-6-12)9-23-13-7-3-11(4-8-13)14-20-15(18)22-16(19)21-14/h1-8H,9H2,(H4,18,19,20,21,22)

Standard InChI Key:  BVSYOXAEHGFKTL-UHFFFAOYSA-N

Associated Targets(Human)

DHFR Tclin Dihydrofolate reductase (3072 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Mycobacterium tuberculosis (203094 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
folA Dihydrofolate reductase (79 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Vero (26788 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 327.78Molecular Weight (Monoisotopic): 327.0887AlogP: 2.94#Rotatable Bonds: 4
Polar Surface Area: 99.94Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 7.13CX LogP: 3.94CX LogD: 3.75
Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.76Np Likeness Score: -1.18

References

1. Yang X, Wedajo W, Yamada Y, Dahlroth SL, Neo JJ, Dick T, Chui WK..  (2018)  1,3,5-triazaspiro[5.5]undeca-2,4-dienes as selective Mycobacterium tuberculosis dihydrofolate reductase inhibitors with potent whole cell activity.,  144  [PMID:29274493] [10.1016/j.ejmech.2017.12.017]
2. He J, Qiao W, An Q, Yang T, Luo Y..  (2020)  Dihydrofolate reductase inhibitors for use as antimicrobial agents.,  195  [PMID:32298876] [10.1016/j.ejmech.2020.112268]

Source